Status:
TERMINATED
Post-lesion Administration of Dexamethasone to Prevent the Development of Neuritis After Radiofrequency Ablation
Lead Sponsor:
Johns Hopkins University
Conditions:
Neuritis
Radiofrequency Ablation
Eligibility:
All Genders
18-90 years
Phase:
PHASE4
Brief Summary
Chronic neck and back pain has become one of the leading causes of disability and loss of productivity. For many patients with facet or sacroiliac joint mediated pain who have responded to diagnostic ...
Eligibility Criteria
Inclusion
- patients with a diagnosis of either cervical, thoracic, or lumbar facet or sacroiliac joint pain who have responded to medial branch blocks and are already scheduled for bilateral radiofrequency ablations
- age greater than 18 years old
- English speaking
Exclusion
- patient not previously scheduled for radiofrequency ablation of the cervical, thoracic, or lumbar facets, or sacroiliac joints
- on anticoagulation
- have a pacemaker
- age less than 18 years old
- non-English speaking
Key Trial Info
Start Date :
September 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 14 2022
Estimated Enrollment :
63 Patients enrolled
Trial Details
Trial ID
NCT03247413
Start Date
September 1 2019
End Date
October 14 2022
Last Update
January 5 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Johns Hopkins Hospital
Baltimore, Maryland, United States, 21287